RFG Advisory’s Palisade Bio PALI Stock Holding History

RFG Advisory’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,750	Closed	-$20.6K	–	1170
2026 Q1	$20.6K	Buy	+11,750	New	+$21.4K	﹤0.01%	1037

Other funds holding PALI

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

RFG Advisory's PALI Position: Q2 2026 in Review

RFG Advisory sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 11,750 shares — an estimated $20.6K sold.

RFG Advisory first reported a position in PALI in Q1 2026 and held it in 1 quarter. The position peaked at $20.6K in Q1 2026. 4 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

RFG Advisory reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
RFG Advisory sold 11,750 Palisade Bio shares in Q2 2026, an estimated $20.6K.
RFG Advisory first reported a position in Palisade Bio in Q1 2026 and held it in 1 quarter.
RFG Advisory's Palisade Bio position peaked at $20.6K in Q1 2026.
4 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.